NeoGenomics
Kendra Sweeney serves as the Vice President of Investor Relations and ESG at NeoGenomics Laboratories since February 2023, where responsibilities include developing and executing the Investor Relations strategy, managing quarterly earnings processes, and enhancing investor relationships. Sweeney has a track record of preparing management teams for investor engagements and establishing a robust ESG program, including the launch of the inaugural ESG report and a sustainability initiative. Prior to NeoGenomics, Sweeney held leadership roles in investor relations and capital markets at Evelo Biosciences and Needham & Company, among others. Educational qualifications include a BA in Advertising and Public Relations, Marketing, and Political Science from the University of Central Florida and a Juris Doctor in Business Law and Financial Services from Suffolk University Law School.
This person is not in any teams
This person is not in any offices
NeoGenomics
9 followers
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years.